FTC Says Authorized Generics Can Aid Competition

Law360, New York (June 25, 2009, 12:00 AM EDT) -- The Federal Trade Commission has said the use of authorized generics may help drive down drug prices, in an interim report that may signal trouble ahead for legislative proposals seeking to curb branded-drug makers' use of authorized generics to give them an edge in settlement negotiations.

In the interim report issued late Wednesday, the FTC said its analysis of the short-term effects of authorized generics found that they could at times provide useful competition to generic drugs. But it noted that there were some potentially troubling...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.